Archives: Speakers

In my current role I work with Microsoft’s Financial Services customers; helping them achieve value-led transformational outcomes with all of Microsoft’s technologies. However, my 30-year career spans all aspects of technology sales and delivery. I’ve worked for tech vendors, tech implementors and consulting firms across many industries around the globe. Transforming customer experience, plus its interplay with colleague experience and operational automation, has been a focus throughout my career. Right now, applying data strategies, AI and generative AI to all aspects of CX is a key focus.

I have been working at Xpedition since August 2021. Specialising in digital transformation strategy, I delight in helping organisations better understand their long-term vision, and working with them to develop their business strategy and achieve their objectives through the implementation of innovative Microsoft solutions. Previously, I worked at Advanced Computer Software Group and DPS Software, holding various roles in new business development.

Richard Gibson currently serves as the Senior FS Marketing Manager at Xpedition, a leading Microsoft Business Solutions Partner and one of only a handful of Microsoft Inner Circle members in the UK. Having joined Xpedition in 2021, Richard specialises in building and delivering value propositions and go-to-market strategies. His focus is on leveraging Xpedition‘s expertise alongside Microsoft technologies to help firms accelerate digital transformation. Richard’s strategies aim to ensure clients are positioned to exceed customer expectations and deliver superior outcomes through the use of Microsoft Dynamics 365, Microsoft Copilot generative AI, and intelligent agents

20+ years of tech leadership in digital native companies and more traditional companies going for deep digital transformation. Strong advocate of “Management 3.0 | Agile Leadership Practices” and of “Tech for Good”. My main leadership values: Transparency, Collaboration, Efficiency, Inclusion, Iteration.

What makes me wake up in a good mood every day is to lead Product and Tech / IT teams to:
– Ideate, Design, Build, Operate products and platforms at scale with a positive impact for the company, the society and the planet
– Architect and turn tech organizations & people into a strategic and high performing contributor to the company,
– Execute the digital | agile | devsecops agendas and transformation from C-level to operational level,
– Re-invent themselves by fostering a startup and “intrapreneurial management” mindset.

I also enjoy advising startups which need to scale up in their tech management practices.

Jaleeysa King is a visionary data analyst who is revolutionizing the link between data analysis, fair market value, and diversity in clinical trials. In her previous role as a Senior Data Delivery Analyst at Greenphire, Jaleeysa was responsible for validating the global fair market value data set and providing insight on investigator grant trends to facilitate more effective site budget negotiations. She has since amplified those skills in her current role as a Product Owner driving product innovation. Also, through her in-depth study of the disparities in patient population diversity in clinical trials, she is creating new ways technology and data can be used to bridge those gaps. By providing support to clients through data analysis and industry changes, she continues to find ways to support the broader data vision of Greenphire.

Dave Hine spent the first half of his career working in the aerospace/defense industry as part of a software development team. While there, he learned about the process, training, and customer support required to make a software solution successful. Today, he applies that experience and passion to clinical trial financial software at Greenphire. He spends his time consulting with sponsors and CROs on the problems, solutions, and impact of payments in clinical trials and also works directly on Greenphire’s innovation team to help them prioritize, design, and deliver new solutions.

As Greenphire’s Chief Commercial Officer, Steven Geffon is responsible for the global commercial strategy of the rapidly growing organization, including the execution of sales and marketing programs. Steve joins Greenphire with over 20 years of experience in technology-enabled solutions for life sciences. He has focused much of his career on generating revenue in high-growth businesses, building successful teams, and creating mature commercial business processes. With his extensive experience as a commercial leader, Steven is committed to advocating for transformative technology solutions and building relationships that drive clinical innovation.

Most recently, Steven served as CCO for Science 37, where he led his team through exponential growth in an emerging eClinical category. Before Science 37, he was responsible for sales, marketing, and corporate development as CCO at Medrio, a leading SaaS eClinical technology platform. Additionally, Steven spent nearly 15 years with Clario, leading Commercial Sales for North America encompassing a team of over 100 individuals and over half a billion in annual sales.

Biography Tim Dorsey is a Team Lead of Product Training at Greenphire, whose mission is to ensure all site and sponsor users understand how to effectively use and maximize Greenphire solutions. Tim and his team conduct live trainings, attend Investigator Meetings, and create In-Application training content for users to access within the products. He has been with Greenphire for 4 years and has a decade of training experience prior to this role.

Nick is the Director of Operations at Leapcure. Leapcure’s mission is to enable equitable clinical trials, aligning the needs of sponsors, sites, and patients. Nick oversees dozens of patient-centric study projects and partnerships, leading the Leapcure team to thousands of impactful, live patient conversations every month, keeping study enrollments on or ahead of schedule. Nick has particular experience synchronizing the interests of patients, sites, and sponsors with rare diseases.